Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Callitas Health Inc (OTC: MPHMF).

Full DD Report for MPHMF

You must become a subscriber to view this report.


Recent News from (OTC: MPHMF)

InvestmentPitch Media Video Discusses Callitas Health's Consulting Agreement with BFS Innovations and Pure Leaf Group for Cannabis Delivery Technology - Video Available on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - August 24, 2018) - Callitas Health Inc. (CSE: LILY) (OTCQB: MPHMF) (FSE: T3F3) has signed a consulting agreement with BFS Innovations and Pure Leaf Group to globally launch the company's patent-pending cannabis delivery technology and proprietary ...
Source: Newsfile
Date: August, 24 2018 09:10
Callitas Health, Inc. Signs Partnership Agreement with BFS Innovations and Pure Leaf Group
CINCINNATI, OH / ACCESSWIRE / August 17, 2018 / Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the "Company" or "Callitas") today announced that it has signed a consulting agreement with BFS Innovations and Pure Leaf Group to launch Callitas' patent-pending cannabis delive...
Source: ACCESSWIRE
Date: August, 17 2018 08:30
Callitas Health Signs Letter of Intent with Lifestyles to Supply Unique Finished Goods for Retail Sale
CINCINNATI, OH, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. , (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today it ha...
Source: GlobeNewswire
Date: August, 14 2018 08:30
Callitas Health, Inc. Receives Full US Patent Grant for Treatment for Male Infertility (and Sub-Fertility)
CINCINNATI, OH, July 25, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc.  (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today tha...
Source: GlobeNewswire
Date: July, 25 2018 08:30
Callitas Health Launches Affiliate Network to Expand Reach for ToConceive
CINCINNATI, OH, July 10, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today it has lau...
Source: GlobeNewswire
Date: July, 10 2018 08:30
Callitas Health signs non-exclusive licensing agreement with Lifestyles, LTD
Callitas ( OTCQB:MPHMF ) entered into a non-exclusive licensing and technology agreement with LifeStyles, LTD for its non-branded, patented arousal gel and lubricants for use on condoms and as a stand-alone product for retail and consumer markets around the world. More news on: Callitas He...
Source: SeekingAlpha
Date: June, 26 2018 12:01
Callitas Health, Inc. Signs Non-Exclusive Licensing Agreement for Patented Arousal Gel Technology & Products with LifeStyles, LTD
CINCINNATI, OH & SOUTH ISELIN, NJ, June 26, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced toda...
Source: GlobeNewswire
Date: June, 26 2018 08:30
James Thompson Elevated to President and Chief Executive Officer of Callitas Health, Inc.
CINCINNATI, OH, June 07, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today that James Thompson w...
Source: GlobeNewswire
Date: June, 07 2018 08:30
Dr. Gregory Smith MD, MPH, Chief Medical Cannabis Advisor for Callitas Health, Releases New Book on THCV
CINCINNATI, OH, June 05, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced that its Chief Medical Canna...
Source: GlobeNewswire
Date: June, 05 2018 10:32
Callitas Health Enters into Exclusive Development and Intellectual Property Agreement for CannaMint Strips and Files Additional Trademarks for CannaStrips and CanRelief
CINCINNATI, OH, May 24, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today that it has...
Source: GlobeNewswire
Date: May, 24 2018 08:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-130.07080.0690.07080.0686103,000
2018-12-120.0760.0760.0760.076970
2018-12-11N/A0.09N/AN/A0
2018-12-100.090.090.090.093,000
2018-12-070.10830.0930.10830.0934,800

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-10-31800800100.0000Short
2018-08-317501,95038.4615Short
2018-08-082,0003,00066.6667Short
2018-07-30800800100.0000Short
2018-07-095,0005,000100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MPHMF.


About Callitas Health Inc (OTC: MPHMF)

Logo for Callitas Health Inc  (OTC: MPHMF)

As a company, our number one goal is helping people by bringing products to market that improve quality of life. All our drug treatments and biomedical technologies fit our mission to deliver breakthrough products and services that reduce invasiveness and enhance daily living. We strive to improve the lives of people facing obesity, infertility and intimacy issues. Our products include ground breaking drug treatments and biomedical technologies, including ToConceive, C and Extrinsa.

 

 

 

Current Management

  • James Thompson / CEO
  • Joshua Maurice / Director, Sales amp Mkt.
  • Richard Skeith / D. Richard Skeith received his BA Hons in Economics in and his law degree in , both from the University of Alberta. He has practiced law in Calgary since then. He is currently a partner with a large international law firm, with a practice focused on public company matters. He is currently or has been an officer or director of various public companies in the mining, oil and gas, pharmaceutical and real estate fields.

Current Share Structure

  • Market Cap: $8,395,326 - 03/09/2018
  • Authorized: 32,166,000 - 12/04/2017
  • Issue and Outstanding: 32,166,000 - 12/04/2017

 


Recent Filings from (OTC: MPHMF)

Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: January, 17 2018
Interim Financial Report - Interim Financial Report
Filing Type: Interim Financial Report - Interim Financial ReportFiling Source: OTC Markets
Filing Date: November, 30 2017
Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: October, 21 2017
Interim Financial Report - Interim Financial Report
Filing Type: Interim Financial Report - Interim Financial ReportFiling Source: OTC Markets
Filing Date: October, 18 2017

 

 


Daily Technical Chart for (OTC: MPHMF)

Daily Technical Chart for (OTC: MPHMF)


Stay tuned for daily updates and more on (OTC: MPHMF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MPHMF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MPHMF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MPHMF and does not buy, sell, or trade any shares of MPHMF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/